PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 63 filers reported holding PRELUDE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,621 | +27.6% | 17,353 | +85.8% | 0.00% | – |
| Q2 2023 | $42,026 | +425.3% | 9,339 | +569.9% | 0.00% | – |
| Q1 2023 | $8,000 | +99900.0% | 1,394 | +7.5% | 0.00% | – |
| Q4 2022 | $8 | -100.0% | 1,297 | -47.1% | 0.00% | – |
| Q3 2022 | $16,000 | +45.5% | 2,451 | +20.6% | 0.00% | – |
| Q2 2022 | $11,000 | -82.8% | 2,033 | -78.1% | 0.00% | – |
| Q1 2022 | $64,000 | -29.7% | 9,264 | +28.2% | 0.00% | – |
| Q4 2021 | $91,000 | -58.6% | 7,224 | +2.9% | 0.00% | – |
| Q3 2021 | $220,000 | +11.7% | 7,019 | +1.9% | 0.00% | – |
| Q2 2021 | $197,000 | -27.8% | 6,889 | +9.4% | 0.00% | – |
| Q1 2021 | $273,000 | -84.4% | 6,295 | -74.3% | 0.00% | – |
| Q4 2020 | $1,753,000 | – | 24,496 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $69,274,000 | 1.12% |
| Baker Brothers Advisors | 10,123,824 | $69,854,000 | 0.40% |
| HHLR ADVISORS, LTD. | 583,333 | $4,025,000 | 0.08% |
| Rock Springs Capital Management LP | 368,959 | $2,546,000 | 0.06% |
| PDT Partners, LLC | 71,822 | $496,000 | 0.04% |
| Virtus ETF Advisers LLC | 13,048 | $90,000 | 0.04% |
| Corton Capital Inc. | 10,918 | $75,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 23,201 | $160,000 | 0.02% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 24,238 | $167,000 | 0.01% |
| IndexIQ Advisors LLC | 56,750 | $392,000 | 0.01% |